Axillary treatment for operable primary breast cancer

Does radical surgery to the axilla give a Survival advantage in more severe breast cancer?

Sinha, Prakash
Thrush, S.
Bendall, Susan
Bates, Tom

July 2002

There is sonic evidence that more radical treatment of the axilla may improve survival in node-posit...

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Boughey, Judy C
Alvarado, Michael D
Lancaster, Rachael B
Fraser Symmans, W
Mukhtar, Rita
Wong, Jasmine M
Ewing, Cheryl A
Potter, David A
Tuttle, Todd M
Hieken, Tina J
Carter, Jodi M
Jakub, James W
Kaplan, Henry G
Buchanan, Claire L
Jaskowiak, Nora T
Sattar, Husain A
Mueller, Jeffrey
Nanda, Rita
Isaacs, Claudine J
Pohlmann, Paula R
Lynce, Filipa
Tousimis, Eleni A
Zeck, Jay C
Lee, M Catherine
Lang, Julie E
Mhawech-Fauceglia, Paulette
Rao, Roshni
Taback, Bret
Chen, Margaret
Kalinsky, Kevin M
Hibshoosh, Hanina
Killelea, Brigid
Sanft, Tara
Hirst, Gillian L
Asare, Smita
Matthews, Jeffrey B
Perlmutter, Jane
Esserman, Laura J

January 2018

Advances in the surgical management of the axilla in patients treated with neoadjuvant chemotherapy,...

POSNOC—POsitive Sentinel NOde : adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy : a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes

Goyal, A.
Mann, G.B.
Fallowfield, L.
Duley, L.
Reed, M.
Dodwell, D.
Coleman, R.E.
Fakis, A.
Newcombe, R.
Jenkins, V.
Whitham, D.
Childs, M.
Whynes, D.
Keeley, V.
Ellis, I.
Fairbrother, P.
Sadiq, S.
Monson, K.
Montgomery, A.
Tan, W.
Vale, L.
Homer, T.
Badger, H.
Haines, R.H.
Lewis, M.
Megias, D.
Nabi, Z.
Singh, P.
Caraman, A.
Miles, E.
POSNOC Trialists, (on behalf of)

December 2021

Introduction: ACOSOG-Z0011(Z11) trial showed that axillary node clearance (ANC) may be omitted in wo...

Axillary dissection versus axillary observation for low risk, clinically node-negative invasive breast cancer : a systematic review and meta-analysis

Sangha, MS
Baker, RD
Ahmed, M

November 2021

1. To systematically analyse studies comparing survival outcomes between axillary lymph-node dissect...

Axillary treatment for patients with early breast cancer and lymph node metastasis: systematic review protocol

Goyal, Amit
Duley, Lelia
Fakis, Apostolos

January 2013

Background: For patients with early breast cancer and lymph node metastasis, axillary treatment is w...

The implications of a pathological complete response of the primary tumour after neoadjuvant chemotherapy for breast cancer on axillary surgery

Youssef, Mina M. G.
Metwally, Ahmed A.
Manie, Tamer M.

February 2021

Background Management of the node-positive axilla after neoadjuvant chemotherapy is controversial. T...

Optimizing the axillary management in breast cancer:from imaging to surgery

Samiei, Sanaz

January 2021

This thesis aimed to provide insights into different aspects of the axillary management of breast ca...

Treatment of the axilla in patients with primary breast cancer and low burden axillary disease: Limitations of the evidence from randomised controlled trials

Robertson, JFR
Herrod, PJJ
Matthew, J
Kilburn, LS
Coles, Charlotte
Bradbury, I

February 2017

Invasive breast cancer is the second most common cancer worldwide. It is known to metastasise to the...

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial

Giuliano, Armando E.
Ballman, Karla V.
McCall, Linda
Beitsch, Peter D.
Brennan, Meghan B.
Kelemen, Pond R.
Ollila, David W.
Hansen, Nora M.
Whitworth, Pat W.
Blumencranz, Peter W.
Leitch, A. Marilyn
Saha, Sukamal
Hunt, Kelly K.
Morrow, Monica

January 2017

The results of the American College of Surgeons Oncology Group Z0011 (ACOSOG Z0011) trial were first...

Clinical outcome of the axilla after axillary radiation in breast cancer: A retrospective study from MNJIO & RCC Hyderabad

Raman

July 2018

Aim: To study the axillary recurrences after calculation of radiation dose delivered to the mid axil...

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

Donker, Mila
van Tienhoven, Geertjan
Straver, Marieke E.
Meijnen, Philip
van de Velde, Cornelis J. H.
Mansel, Robert E.
Cataliotti, Luigi
Westenberg, A. Helen
Klinkenbijl, Jean H. G.
Orzalesi, Lorenzo
Bouma, Willem H.
van der Mijle, Huub C. J.
Nieuwenhuijzen, Grard A. P.
Veltkamp, Sanne C.
Slaets, Leen
Duez, Nicole J.
de Graaf, Peter W.
van Dalen, Thijs
Marinelli, Andreas
Rijna, Herman
Snoj, Marko
Bundred, Nigel J.
Merkus, Jos W. S.
Belkacemi, Yazid
Petignat, Patrick
Schinagl, Dominic A. X.
Coens, Corneel
Messina, Carlo G. M.
Bogaerts, Jan
Rutgers, Emiel J. T.

January 2014

If treatment of the axilla is indicated in patients with breast cancer who have a positive sentinel ...

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy : a Dutch randomized controlled multicentre trial (BOOG 2013-07)

van Roozendaal, LM
de Wilt, JHW
van Dalen, T
van der Hage, JA
Strobbe, LJA
Boersma, LJ
Linn, SC
Lobbes, MBI
Poortmans, PMP
Tjan-Heijnen, VCG
Van de Vijver, Koen
de Vries, J
Westenberg, AH
Kessels, AGH
Smidt, ML

January 2015

Background: Trials failed to demonstrate additional value of completion axillary lymph node dissecti...

Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer

MARRAZZO, Antonio
DAMIANO, Giuseppe
Taormina, P.
Buscemi, Salvatore
LO MONTE, Attilio Ignazio
MARRAZZO, Emilia

January 2016

The role of axillary surgery for early breast carcinoma treated with conservative surgery and radiot...

Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Weber, Walter P
Matrai, Zoltan
Hayoz, Stefanie
Tausch, Christoph
Henke, Guido
Zwahlen, Daniel R
Gruber, Günther
Zimmermann, Frank
Seiler, Stefanie
Maddox, Charlotte
Ruhstaller, Thomas
Muenst, Simone
Ackerknecht, Markus
Kuemmel, Sherko
Bjelic-Radisic, Vesna
Kurzeder, Christian
Újhelyi, Mihály
Vrieling, Conny
Satler, Rok
Meyer, Inna
Becciolini, Charles
Bucher, Susanne
Simonson, Colin
Fehr, Peter M
Gabriel, Natalie
Maráz, Robert
Sarlos, Dimitri
Dedes, Konstantin J
Leo, Cornelia
Berclaz, Gilles
et al

December 2021

Aim: We developed tailored axillary surgery (TAS) to reduce the axillary tumor volume in patients wi...

Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer

Simons, J.M.
van Nijnatten, TJA
van der Pol, C.C.
Luiten, E.J.T.
Koppert, L.B. (Linetta)
Smidt, M.L.

January 2019

Objective: The aim of this study was to perform a systematic review and meta-analysis to assess the...

Does radical surgery to the axilla give a Survival advantage in more severe breast cancer?

Sinha, Prakash
Thrush, S.
Bendall, Susan
Bates, Tom

July 2002

There is sonic evidence that more radical treatment of the axilla may improve survival in node-posit...

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Boughey, Judy C
Alvarado, Michael D
Lancaster, Rachael B
Fraser Symmans, W
Mukhtar, Rita
Wong, Jasmine M
Ewing, Cheryl A
Potter, David A
Tuttle, Todd M
Hieken, Tina J
Carter, Jodi M
Jakub, James W
Kaplan, Henry G
Buchanan, Claire L
Jaskowiak, Nora T
Sattar, Husain A
Mueller, Jeffrey
Nanda, Rita
Isaacs, Claudine J
Pohlmann, Paula R
Lynce, Filipa
Tousimis, Eleni A
Zeck, Jay C
Lee, M Catherine
Lang, Julie E
Mhawech-Fauceglia, Paulette
Rao, Roshni
Taback, Bret
Chen, Margaret
Kalinsky, Kevin M
Hibshoosh, Hanina
Killelea, Brigid
Sanft, Tara
Hirst, Gillian L
Asare, Smita
Matthews, Jeffrey B
Perlmutter, Jane
Esserman, Laura J

January 2018

Advances in the surgical management of the axilla in patients treated with neoadjuvant chemotherapy,...

POSNOC—POsitive Sentinel NOde : adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy : a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes

Goyal, A.
Mann, G.B.
Fallowfield, L.
Duley, L.
Reed, M.
Dodwell, D.
Coleman, R.E.
Fakis, A.
Newcombe, R.
Jenkins, V.
Whitham, D.
Childs, M.
Whynes, D.
Keeley, V.
Ellis, I.
Fairbrother, P.
Sadiq, S.
Monson, K.
Montgomery, A.
Tan, W.
Vale, L.
Homer, T.
Badger, H.
Haines, R.H.
Lewis, M.
Megias, D.
Nabi, Z.
Singh, P.
Caraman, A.
Miles, E.
POSNOC Trialists, (on behalf of)

December 2021

Introduction: ACOSOG-Z0011(Z11) trial showed that axillary node clearance (ANC) may be omitted in wo...

Axillary dissection versus axillary observation for low risk, clinically node-negative invasive breast cancer : a systematic review and meta-analysis

Sangha, MS
Baker, RD
Ahmed, M

November 2021

1. To systematically analyse studies comparing survival outcomes between axillary lymph-node dissect...

Axillary treatment for patients with early breast cancer and lymph node metastasis: systematic review protocol

Goyal, Amit
Duley, Lelia
Fakis, Apostolos

January 2013

Background: For patients with early breast cancer and lymph node metastasis, axillary treatment is w...

The implications of a pathological complete response of the primary tumour after neoadjuvant chemotherapy for breast cancer on axillary surgery

Youssef, Mina M. G.
Metwally, Ahmed A.
Manie, Tamer M.

February 2021

Background Management of the node-positive axilla after neoadjuvant chemotherapy is controversial. T...

Optimizing the axillary management in breast cancer:from imaging to surgery

Samiei, Sanaz

January 2021

This thesis aimed to provide insights into different aspects of the axillary management of breast ca...

Treatment of the axilla in patients with primary breast cancer and low burden axillary disease: Limitations of the evidence from randomised controlled trials

Robertson, JFR
Herrod, PJJ
Matthew, J
Kilburn, LS
Coles, Charlotte
Bradbury, I

February 2017

Invasive breast cancer is the second most common cancer worldwide. It is known to metastasise to the...

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial

Giuliano, Armando E.
Ballman, Karla V.
McCall, Linda
Beitsch, Peter D.
Brennan, Meghan B.
Kelemen, Pond R.
Ollila, David W.
Hansen, Nora M.
Whitworth, Pat W.
Blumencranz, Peter W.
Leitch, A. Marilyn
Saha, Sukamal
Hunt, Kelly K.
Morrow, Monica

January 2017

The results of the American College of Surgeons Oncology Group Z0011 (ACOSOG Z0011) trial were first...

Clinical outcome of the axilla after axillary radiation in breast cancer: A retrospective study from MNJIO & RCC Hyderabad

Raman

July 2018

Aim: To study the axillary recurrences after calculation of radiation dose delivered to the mid axil...

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

Donker, Mila
van Tienhoven, Geertjan
Straver, Marieke E.
Meijnen, Philip
van de Velde, Cornelis J. H.
Mansel, Robert E.
Cataliotti, Luigi
Westenberg, A. Helen
Klinkenbijl, Jean H. G.
Orzalesi, Lorenzo
Bouma, Willem H.
van der Mijle, Huub C. J.
Nieuwenhuijzen, Grard A. P.
Veltkamp, Sanne C.
Slaets, Leen
Duez, Nicole J.
de Graaf, Peter W.
van Dalen, Thijs
Marinelli, Andreas
Rijna, Herman
Snoj, Marko
Bundred, Nigel J.
Merkus, Jos W. S.
Belkacemi, Yazid
Petignat, Patrick
Schinagl, Dominic A. X.
Coens, Corneel
Messina, Carlo G. M.
Bogaerts, Jan
Rutgers, Emiel J. T.

January 2014

If treatment of the axilla is indicated in patients with breast cancer who have a positive sentinel ...

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy : a Dutch randomized controlled multicentre trial (BOOG 2013-07)

van Roozendaal, LM
de Wilt, JHW
van Dalen, T
van der Hage, JA
Strobbe, LJA
Boersma, LJ
Linn, SC
Lobbes, MBI
Poortmans, PMP
Tjan-Heijnen, VCG
Van de Vijver, Koen
de Vries, J
Westenberg, AH
Kessels, AGH
Smidt, ML

January 2015

Background: Trials failed to demonstrate additional value of completion axillary lymph node dissecti...

Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer

MARRAZZO, Antonio
DAMIANO, Giuseppe
Taormina, P.
Buscemi, Salvatore
LO MONTE, Attilio Ignazio
MARRAZZO, Emilia

January 2016

The role of axillary surgery for early breast carcinoma treated with conservative surgery and radiot...

Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Weber, Walter P
Matrai, Zoltan
Hayoz, Stefanie
Tausch, Christoph
Henke, Guido
Zwahlen, Daniel R
Gruber, Günther
Zimmermann, Frank
Seiler, Stefanie
Maddox, Charlotte
Ruhstaller, Thomas
Muenst, Simone
Ackerknecht, Markus
Kuemmel, Sherko
Bjelic-Radisic, Vesna
Kurzeder, Christian
Újhelyi, Mihály
Vrieling, Conny
Satler, Rok
Meyer, Inna
Becciolini, Charles
Bucher, Susanne
Simonson, Colin
Fehr, Peter M
Gabriel, Natalie
Maráz, Robert
Sarlos, Dimitri
Dedes, Konstantin J
Leo, Cornelia
Berclaz, Gilles
et al

December 2021

Aim: We developed tailored axillary surgery (TAS) to reduce the axillary tumor volume in patients wi...

Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer

Simons, J.M.
van Nijnatten, TJA
van der Pol, C.C.
Luiten, E.J.T.
Koppert, L.B. (Linetta)
Smidt, M.L.

January 2019

Objective: The aim of this study was to perform a systematic review and meta-analysis to assess the...

Does radical surgery to the axilla give a Survival advantage in more severe breast cancer?

Sinha, Prakash
Thrush, S.
Bendall, Susan
Bates, Tom

July 2002

There is sonic evidence that more radical treatment of the axilla may improve survival in node-posit...

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Boughey, Judy C
Alvarado, Michael D
Lancaster, Rachael B
Fraser Symmans, W
Mukhtar, Rita
Wong, Jasmine M
Ewing, Cheryl A
Potter, David A
Tuttle, Todd M
Hieken, Tina J
Carter, Jodi M
Jakub, James W
Kaplan, Henry G
Buchanan, Claire L
Jaskowiak, Nora T
Sattar, Husain A
Mueller, Jeffrey
Nanda, Rita
Isaacs, Claudine J
Pohlmann, Paula R
Lynce, Filipa
Tousimis, Eleni A
Zeck, Jay C
Lee, M Catherine
Lang, Julie E
Mhawech-Fauceglia, Paulette
Rao, Roshni
Taback, Bret
Chen, Margaret
Kalinsky, Kevin M
Hibshoosh, Hanina
Killelea, Brigid
Sanft, Tara
Hirst, Gillian L
Asare, Smita
Matthews, Jeffrey B
Perlmutter, Jane
Esserman, Laura J

January 2018

Advances in the surgical management of the axilla in patients treated with neoadjuvant chemotherapy,...

POSNOC—POsitive Sentinel NOde : adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy : a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes

Goyal, A.
Mann, G.B.
Fallowfield, L.
Duley, L.
Reed, M.
Dodwell, D.
Coleman, R.E.
Fakis, A.
Newcombe, R.
Jenkins, V.
Whitham, D.
Childs, M.
Whynes, D.
Keeley, V.
Ellis, I.
Fairbrother, P.
Sadiq, S.
Monson, K.
Montgomery, A.
Tan, W.
Vale, L.
Homer, T.
Badger, H.
Haines, R.H.
Lewis, M.
Megias, D.
Nabi, Z.
Singh, P.
Caraman, A.
Miles, E.
POSNOC Trialists, (on behalf of)

December 2021

Introduction: ACOSOG-Z0011(Z11) trial showed that axillary node clearance (ANC) may be omitted in wo...

Axillary treatment for operable primary breast cancer

Abstract

Extracted data

Axillary treatment for operable primary breast cancer

Abstract

Extracted data

Related items

Related items